Starting the new patient on oral contraceptives.

Research output: Contribution to journalArticle

Abstract

There are many considerations prior to starting a patient on oral contraceptives (OCs). A careful history and physical examination should be obtained, as should laboratory studies where indicated. In addition to the absolute and relative contraindications to OCs, the benefits should be reviewed with the patient. During therapy, the patient should be advised regarding potential minor side effects as well as serious signs and symptoms. There appears to be little difference in efficacy or side effects of monophasic vs. multiphasic contraceptives. It is recommended that a pill containing the lowest hormonal content, and thus with the least potential for side effects (ie, 35 micrograms of ethinyl estradiol), be utilized.

Original languageEnglish (US)
Pages (from-to)21-26
Number of pages6
JournalInternational Journal of Fertility
Volume33 Suppl
StatePublished - 1988

Fingerprint

Oral Contraceptives
Ethinyl Estradiol
Contraceptive Agents
Signs and Symptoms
Physical Examination
History
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Starting the new patient on oral contraceptives. / Carr, B. R.

In: International Journal of Fertility, Vol. 33 Suppl, 1988, p. 21-26.

Research output: Contribution to journalArticle

@article{3bffe5fac6164ba68e2c665652e7b9ab,
title = "Starting the new patient on oral contraceptives.",
abstract = "There are many considerations prior to starting a patient on oral contraceptives (OCs). A careful history and physical examination should be obtained, as should laboratory studies where indicated. In addition to the absolute and relative contraindications to OCs, the benefits should be reviewed with the patient. During therapy, the patient should be advised regarding potential minor side effects as well as serious signs and symptoms. There appears to be little difference in efficacy or side effects of monophasic vs. multiphasic contraceptives. It is recommended that a pill containing the lowest hormonal content, and thus with the least potential for side effects (ie, 35 micrograms of ethinyl estradiol), be utilized.",
author = "Carr, {B. R.}",
year = "1988",
language = "English (US)",
volume = "33 Suppl",
pages = "21--26",
journal = "International Journal of Fertility",
issn = "0020-725X",
publisher = "MSP International",

}

TY - JOUR

T1 - Starting the new patient on oral contraceptives.

AU - Carr, B. R.

PY - 1988

Y1 - 1988

N2 - There are many considerations prior to starting a patient on oral contraceptives (OCs). A careful history and physical examination should be obtained, as should laboratory studies where indicated. In addition to the absolute and relative contraindications to OCs, the benefits should be reviewed with the patient. During therapy, the patient should be advised regarding potential minor side effects as well as serious signs and symptoms. There appears to be little difference in efficacy or side effects of monophasic vs. multiphasic contraceptives. It is recommended that a pill containing the lowest hormonal content, and thus with the least potential for side effects (ie, 35 micrograms of ethinyl estradiol), be utilized.

AB - There are many considerations prior to starting a patient on oral contraceptives (OCs). A careful history and physical examination should be obtained, as should laboratory studies where indicated. In addition to the absolute and relative contraindications to OCs, the benefits should be reviewed with the patient. During therapy, the patient should be advised regarding potential minor side effects as well as serious signs and symptoms. There appears to be little difference in efficacy or side effects of monophasic vs. multiphasic contraceptives. It is recommended that a pill containing the lowest hormonal content, and thus with the least potential for side effects (ie, 35 micrograms of ethinyl estradiol), be utilized.

UR - http://www.scopus.com/inward/record.url?scp=0024243534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024243534&partnerID=8YFLogxK

M3 - Article

VL - 33 Suppl

SP - 21

EP - 26

JO - International Journal of Fertility

JF - International Journal of Fertility

SN - 0020-725X

ER -